View in EDS HTML Full Text PDF Full Text

Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1.

Saved in:
Bibliographic Details
Title: Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1.
Authors: Criscuolo E; Department of Experimental Medicine, Tor Vergata University of Rome, Via Montpellier 1, 00121 Rome, Italy., De Sciscio ML; Department of Medicine, Campus Bio-Medico University of Rome, Via Alvaro del Portillo 21, 00128 Rome, Italy., De Cristofaro A; Department of Medicine, Campus Bio-Medico University of Rome, Via Alvaro del Portillo 21, 00128 Rome, Italy., Nicoara C; Department of Experimental Medicine, Tor Vergata University of Rome, Via Montpellier 1, 00121 Rome, Italy., Maccarrone M; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio, Coppito, 67100 L'Aquila, Italy.; European Center for Brain Research/Santa Lucia Foundation IRCCS, Via Del Fosso di Fiorano 64, 00143 Rome, Italy., Fezza F; Department of Experimental Medicine, Tor Vergata University of Rome, Via Montpellier 1, 00121 Rome, Italy.
Source: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2023 Dec 02; Vol. 16 (12). Date of Electronic Publication: 2023 Dec 02.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38139805
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Criscuolo+E%22">Criscuolo E</searchLink>; Department of Experimental Medicine, Tor Vergata University of Rome, Via Montpellier 1, 00121 Rome, Italy.<br /><searchLink fieldCode="AU" term="%22De+Sciscio+ML%22">De Sciscio ML</searchLink>; Department of Medicine, Campus Bio-Medico University of Rome, Via Alvaro del Portillo 21, 00128 Rome, Italy.<br /><searchLink fieldCode="AU" term="%22De+Cristofaro+A%22">De Cristofaro A</searchLink>; Department of Medicine, Campus Bio-Medico University of Rome, Via Alvaro del Portillo 21, 00128 Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Nicoara+C%22">Nicoara C</searchLink>; Department of Experimental Medicine, Tor Vergata University of Rome, Via Montpellier 1, 00121 Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Maccarrone+M%22">Maccarrone M</searchLink>; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, Via Vetoio, Coppito, 67100 L'Aquila, Italy.; European Center for Brain Research/Santa Lucia Foundation IRCCS, Via Del Fosso di Fiorano 64, 00143 Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Fezza+F%22">Fezza F</searchLink>; Department of Experimental Medicine, Tor Vergata University of Rome, Via Montpellier 1, 00121 Rome, Italy.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101238453%22">Pharmaceuticals (Basel, Switzerland)</searchLink> [Pharmaceuticals (Basel)] 2023 Dec 02; Vol. 16 (12). <i>Date of Electronic Publication: </i>2023 Dec 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22MDPI%22">MDPI </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101238453 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>1424-8247 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214248247%22">14248247 </searchLink><i>NLM ISO Abbreviation: </i>Pharmaceuticals (Basel) <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38139805
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3390/ph16121678
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Criscuolo E
      – PersonEntity:
          Name:
            NameFull: De Sciscio ML
      – PersonEntity:
          Name:
            NameFull: De Cristofaro A
      – PersonEntity:
          Name:
            NameFull: Nicoara C
      – PersonEntity:
          Name:
            NameFull: Maccarrone M
      – PersonEntity:
          Name:
            NameFull: Fezza F
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 12
              Text: 2023 Dec 02
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-print
              Value: 1424-8247
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 12
          Titles:
            – TitleFull: Pharmaceuticals (Basel, Switzerland)
              Type: main
ResultId 1